Elevance Health, Inc.

ELVSEC EDGAR

Hospital & Medical Service Plans(IN)CIK: 1156039

Concept	FY2025	FY2024	FY2023	FY2022	FY2021
Revenues	$171.3B	$156.6B	$138.6B	$121.9B	$104.2B
Cost of Goods and Services Sold	$17.3B	$13.0B	$10.9B	$9.0B	$2.0B
Selling, General and Administrative Expense	$20.1B	$17.7B	$15.9B	$17.4B	$13.4B
Operating Income (Loss)	$8.5B	$8.3B	$7.6B	$6.4B	$6.0B
Interest Expense	—	—	$798.0M	$784.0M	$746.0M
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	$7.7B	$7.6B	$8.0B	$6.2B	$6.0B
Income Tax Expense (Benefit)	$1.7B	$1.7B	$1.8B

Concept	FY2025	FY2024	FY2023	FY2022	FY2021
Assets	$116.9B	$108.9B	$102.8B	$97.5B	$86.6B
Assets, Current	$58.9B	$60.0B	$55.6B	$51.1B	$45.8B
Cash and Cash Equivalents, at Carrying Value	$8.3B	$6.5B	$7.4B	$4.9B	$3.9B
Liabilities	$75.5B	$69.5B	$66.4B	$61.3B	$53.4B
Liabilities, Current	$40.6B	$41.8B	$39.7B	$34.9B	$29.5B
Long-term Debt	$30.9B	$24.9B	$23.8B	$22.8B	$20.0B
Stockholders' Equity Attributable to Parent	$41.3B	$39.3B	$36.2B	$36.1B

Concept	FY2025	FY2024	FY2023	FY2022	FY2021
Net Cash Provided by (Used in) Operating Activities	$8.1B	$8.4B	$8.4B	$10.7B	$6.1B
Net Cash Provided by (Used in) Investing Activities	-$5.6B	-$4.6B	-$9.6B	-$7.3B	-$2.8B
Net Cash Provided by (Used in) Financing Activities	-$3.3B	-$1.3B	$423.0M	-$2.6B	-$2.3B
Payments to Acquire Property, Plant, and Equipment	$1.3B	$1.2B	$1.1B	$1.0B	$1.1B
Payments of Dividends	$1.4B	$1.2B	$1.1B	$954.0M	$818.0M
Payments for Repurchase of Common Stock	$2.7B	$2.3B	$1.9B	$2.7B	$1.7B

Access SEC EDGAR data via REST API. Free tier available.

from sec_edgar import SecEdgar

api = SecEdgar("YOUR_KEY")
api.revenue("AAPL", limit=5)